These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 3262098)

  • 1. Production of monoclonal human antibody to HLA-DR5 (DRw11) by mouse/human heterohybridomas.
    Hancock RJ; Martin A; Laundy GJ; Smythe J; Roberts I; Cooke H; Pera S; Bowerman P; Bradley BA
    Hum Immunol; 1988 Jun; 22(2):135-42. PubMed ID: 3262098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro production of anti-HLA-DR antibodies by human B-cell lines.
    Hancock RJ; Martin A; Stinchcombe V; Jones TJ; Smythe J; Laundy GJ; Bradley BA
    Tissue Antigens; 1986 Oct; 28(4):228-32. PubMed ID: 3492781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production of two human hybridomas secreting antibodies to HLA-DRw11 and--DRw8+w12 specificities.
    Pistillo MP; Mazzoleni O; Kun L; Falco M; Tazzari PL; Ferrara GB
    Hum Immunol; 1991 Jun; 31(2):86-93. PubMed ID: 1712351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production of a cytotoxic human monoclonal antibody with specificity for HLA-DR4 and -DRw10 by cells derived from a highly sensitized kidney recipient.
    Yendle JE; Bowerman PD; Yousaf K; Roberts IM; Cohen B; Barber L; Lechler R; Hancock RJ; Bradley BA
    Hum Immunol; 1990 Mar; 27(3):167-81. PubMed ID: 1971267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The production of a human monoclonal antibody defining a split of HLA-DRw13 (DRw13b).
    Bunce M; Sutton PM; Ting A; Morris PJ
    Tissue Antigens; 1990 Sep; 36(3):100-2. PubMed ID: 2126151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A cytotoxic monoclonal antibody (HU-39) that detects DRw8 + DRw12.
    Nakayama T; Ogasawara K; Ikeda H; Kunikane H; Kasahara M; Ishikawa N; Fukasawa Y; Hawkin S; Kojima H; Wakisaka A
    Hum Immunol; 1987 Jun; 19(2):117-26. PubMed ID: 3497138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficient production of stable, human monoclonal antibody-secreting hybridomas from EBV-transformed lymphocytes using the mouse myeloma X63-Ag8.653 as a fusion partner.
    Thompson KM; Hough DW; Maddison PJ; Melamed MD; Hughes-Jones N
    J Immunol Methods; 1986 Nov; 94(1-2):7-12. PubMed ID: 3023493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A cytotoxic human-human hybridoma antibody (TrH6) specific for HLA-DRw52.
    Kolstad A; Hansen T; Hannestad K
    Tissue Antigens; 1988 Feb; 31(2):90-7. PubMed ID: 2836964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production of human monoclonal antibodies to B lymphocyte cell surface antigens by in vitro immunization and human-human hybridoma technology.
    Power DA; Gerkis V; d'Apice AJ
    Hum Antibodies Hybridomas; 1990; 1(1):34-41. PubMed ID: 2103351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new supertypic HLA class II determinant (PL2) differentially expressed with DR7, DRw11(5), DRw13(w6), DRw14(w6), DR3, and DR2 and biochemically localized to DR7 molecules.
    Horibe K; Knowles RW; Dupont B
    Hum Immunol; 1986 May; 16(1):14-23. PubMed ID: 2423484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A monoclonal antibody with broad anti-HLA-DR activity fails to bind to DRw11/Dw5: possible effect of a unique polymorphism on the beta 1 domain alpha-helix.
    Mackworth-Young CG; Kevany M; Lombardi G; Sidhu S; Sharrock C; Batchelor JR; Lechler RI
    Hum Immunol; 1991 Mar; 30(3):174-82. PubMed ID: 2055782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A human hybridoma monoclonal antibody (TrJ11) recognizing a new HLA-DR epitope shared by DR4, DR8, DR11, and DRB1*1303.
    Ge J; Bratlie A; Hannestad K
    Hum Immunol; 1995 Jan; 42(1):27-34. PubMed ID: 7538497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production of an HLA-DRw13 antibody in a DRw14 positive multiparous woman.
    Darke C; Street J
    Tissue Antigens; 1987 Jul; 30(1):42-7. PubMed ID: 3672492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA-D region epitopes associated with juvenile arthritis. Recognition by alloreactive T cell clones and alloantisera.
    Myers LK; Ball EJ; Nunez G; Fink CW; Stastny P
    Arthritis Rheum; 1987 Jul; 30(7):744-51. PubMed ID: 2441709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serological biochemical and functional characterisation of three different HLA-DR monoclonal antibodies derived from C57BL6 mice.
    Sachs JA; Fernandez N; Kurpisz M; Okoye R; Ogilvie J; Awad J; Labeta M; Festenstein H
    Tissue Antigens; 1986 Oct; 28(4):199-207. PubMed ID: 2949394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A human monoclonal antibody to an HLA-DRw53 (MT3)-like epitope on class II antigens.
    Kosinski S; Hämmerling U; Yang SY
    Tissue Antigens; 1986 Sep; 28(3):150-62. PubMed ID: 2431513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential expression of DRw52-like determinants detected by monoclonal antibodies.
    Koning F; Giphart M; Termijtelen A; Bruning H
    Scand J Immunol; 1987 Feb; 25(2):127-31. PubMed ID: 2434986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular analysis of the HLA-DR5 haplotype.
    Ballas M; Madrigal A; Bontrop R; Giphart MJ; Bodmer J; Goldmann SF
    Tissue Antigens; 1989 Oct; 34(4):223-32. PubMed ID: 2617512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production of anti-tumor human monoclonal antibodies using different approaches.
    Liu H; Xu ZL; Wang Y; Yang L; Feng O; Li Y; Wang YM; Zhang GG
    Hum Antibodies Hybridomas; 1993 Jan; 4(1):2-8. PubMed ID: 8381684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SFR3-DR5, a monoclonal antibody with HLA-DR5 specificity.
    Radka SF; Machamer C; Cresswell P; Kostyu DD; Ward FE; Amos DB
    J Immunol; 1983 Apr; 130(4):1863-6. PubMed ID: 6187822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.